Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Gene Rep. 2017 Dec 28;10:149–156. doi: 10.1016/j.genrep.2017.12.004

Figure 2.

Figure 2

(A) Experimental timeline for harvesting mRNA. (B) RT-qPCR analysis of expression of the proliferation marker MKI67, normalized to GAPDH and (C) fold change in all 4 treatment groups (Control = PL alone; FGF2, GDF5, FGF2 + GDF5) compared to untreated day 1 MSCs.